Chikungunya Rapid Test (IGG/IGM)

The Chikungunya Rapid Test (IgG/IgM) is a rapid chikungunya screening test designed to support the early detection and can help to diagnose chikungunya infection, a mosquito-borne viral disease that is commonly reported during the monsoon and post-monsoon seasons in India. Transmitted by infected Aedes mosquitoes, chikungunya can cause symptoms such as sudden high fever, severe joint pain, muscle aches, headache, fatigue, and skin rashes. Since these symptoms often overlap with those of dengue and other viral infections, timely chikungunya testing is important for accurate diagnosis and appropriate medical care.

This chikungunya antibody test measures both IgM and IgG antibodies produced by the body’s immune system in response to the chikungunya virus. IgM antibodies may indicate a recent infection, while IgG antibodies may suggest past exposure or a later stage of infection. By assessing both markers together, the test provides a more comprehensive chikungunya screening than a single antibody test alone. However, antibodies may not be detectable during the very early phase of infection, and test results should always be interpreted alongside symptoms, medical history, and other clinical findings.

Suitable for individuals experiencing chikungunya symptoms, those living in mosquito-prone regions, or people recently exposed to areas reporting chikungunya cases, this package offers a convenient approach to chikungunya diagnosis. Requiring only a blood sample and no fasting, the Chikungunya Rapid Test (IgG/IgM) provides quick diagnostic insights and can be particularly useful when symptoms first appear, enabling timely evaluation and informed healthcare decisions.